PCI Biotech: Expansion of preclinical research collaboration agreement with AstraZeneca
(WorldNews Norway)

PCI Biotech: Expansion of preclinical research collaboration agreement with AstraZeneca Oslo (Norway), 26 November 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced an expansion of its preclinical research collaboration with AstraZeneca. The collaboration was initiated in September 2015 to determine whether PCI Biotech`s fimaNAc technology has the potential to enhance the delivery of AstraZeneca`s nucleic acid therapeutic compounds. The aim of today`s expansion is to...